Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Enavatuzumab Biosimilar – Anti-TNFRSF12A, CD266 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade |
|---|---|
| Source | CAS 1062149-33-0 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Enavatuzumab,PDL 192,TNFRSF12A, CD266,anti-TNFRSF12A, CD266 |
| Reference | PX-TA1253 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade
General information on Anti-TNFRSF12A/CD266[Homo sapiens] (Enavatuzumab) Monoclonal Antibody
Enavatuzumab is a humanized monoclonal antibody that targets the TWEAK receptor. It has been investigated for the treatment of cancers.
Related products
Antigen
TNFRSF12A recombinant protein
PX-P5208 420€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.